PubRank

B Massie

Author PubWeight™ 127.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dipyridamole thallium-201 scintigraphy as a preoperative screening test. A reexamination of its predictive potential. Study of Perioperative Ischemia Research Group. Circulation 1991 3.63
2 Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol 1997 3.39
3 The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol Cell Biol 2000 2.69
4 The heart in hypertension. N Engl J Med 1992 2.53
5 The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 1995 2.39
6 The TrkB-Shc site signals neuronal survival and local axon growth via MEK and P13-kinase. Neuron 2000 1.95
7 The DNA-binding activity of the human heat shock transcription factor is regulated in vivo by hsp70. Mol Cell Biol 1993 1.76
8 Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells. Hum Gene Ther 1994 1.74
9 Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension. Am J Cardiol 1984 1.66
10 Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. J Am Coll Cardiol 1989 1.61
11 Intracellular synthesis, processing, and transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and respiratory syndrome virus. Virology 1996 1.55
12 Central basis of muscle fatigue in chronic fatigue syndrome. Neurology 1993 1.52
13 Induction of apoptosis in nutrient-deprived cultures of hybridoma and myeloma cells. Biotechnol Bioeng 1994 1.47
14 Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. Eur Heart J 2001 1.46
15 Hsp72-mediated suppression of c-Jun N-terminal kinase is implicated in development of tolerance to caspase-independent cell death. Mol Cell Biol 2000 1.42
16 A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum Mol Genet 1994 1.41
17 Deleterious effects of hydralazine in patients with pulmonary hypertension. N Engl J Med 1982 1.38
18 Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements. Circulation 1981 1.35
19 Scale-up of the adenovirus expression system for the production of recombinant protein in human 293S cells. Cytotechnology 1994 1.31
20 Oral hydralazine therapy for chronic refractory heart failure. Circulation 1976 1.30
21 Ventricular arrhythmias in patients undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA 1992 1.30
22 Maximization of recombinant protein yield in the insect cell/baculovirus system by one-time addition of nutrients to high-density batch cultures. Cytotechnology 1994 1.19
23 Gene transfer into skeletal muscles by isogenic myoblasts. Hum Gene Ther 1994 1.19
24 Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine 1993 1.16
25 Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. Am J Cardiol 1977 1.16
26 Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum Gene Ther 1996 1.14
27 Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction. Am J Med 2001 1.14
28 Use of a dicistronic expression cassette encoding the green fluorescent protein for the screening and selection of cells expressing inducible gene products. Biotechniques 1997 1.11
29 Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route. Hum Gene Ther 2000 1.06
30 Expression of bicistronic measles virus P/C mRNA by using hybrid adenoviruses: levels of C protein synthesized in vivo are unaffected by the presence or absence of the upstream P initiator codon. J Virol 1988 1.06
31 Improvement of recombinant protein production with the human adenovirus/293S expression system using fed-batch strategies. Biotechnol Bioeng 1996 1.05
32 Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice. Gene Ther 1996 1.05
33 Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants. Gene Ther 1994 1.03
34 Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells. Biotechnol Bioeng 1998 1.02
35 Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenoviral recombinants. Exp Mol Pathol 1995 1.01
36 A subset of porcine reproductive and respiratory syndrome virus GP3 glycoprotein is released into the culture medium of cells as a non-virion-associated and membrane-free (soluble) form. J Virol 1998 1.00
37 Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles. Hum Gene Ther 1999 0.99
38 Reduced thermotolerance in aged cells results from a loss of an hsp72-mediated control of JNK signaling pathway. Cell Stress Chaperones 1998 0.97
39 The transcription factor E2F1 modulates apoptosis of neurons. J Neurochem 2000 0.97
40 Functional analysis of N-linked glycosylation mutants of the measles virus fusion protein synthesized by recombinant vaccinia virus vectors. J Virol 1994 0.96
41 High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression. Hum Gene Ther 1998 0.96
42 Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide. Ann Intern Med 1987 0.95
43 Construction of a helper-free recombinant adenovirus that expresses polyomavirus large T antigen. Mol Cell Biol 1986 0.94
44 A nonstructural and antigenic glycoprotein is encoded by ORF3 of the IAF-Klop strain of porcine reproductive and respiratory syndrome virus. Arch Virol 1998 0.94
45 Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure. Br J Clin Pharmacol 1982 0.93
46 Naturally occurring R.ColBM plasmids belonging to the IncFIII incompatibility group. J Gen Microbiol 1980 0.93
47 Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice. Physiol Genomics 2000 0.92
48 Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial. Circulation 1985 0.92
49 Proneuropeptide Y processing in large dense-core vesicles: manipulation of prohormone convertase expression in sympathetic neurons using adenoviruses. J Neurosci 1996 0.91
50 Affinity purification of active subunit 1 of herpes simplex virus type 1 ribonucleotide reductase exhibiting a protein kinase activity. J Biol Chem 1991 0.91
51 Generation, validation, and large scale production of adenoviral recombinants with large size inserts such as a 6.3 kb human dystrophin cDNA. J Virol Methods 1997 0.91
52 Chronic aortic insufficiency: factors associated with progression to aortic valve replacement. Ann Intern Med 1989 0.90
53 Long-term perfusion culture of hybridoma: a "grow or die" cell cycle system. Biotechnol Bioeng 1991 0.90
54 Transfection of large plasmids in primary human myoblasts. Gene Ther 2001 0.90
55 Filtration-based perfusion of hybridoma cultures in protein-free medium: Reduction of membrane fouling by medium supplementation with DNase I. Biotechnol Bioeng 1994 0.90
56 Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm. Am J Respir Cell Mol Biol 1995 0.90
57 Long-term vasodilator therapy of chronic aortic insufficiency. A randomized double-blinded, placebo-controlled clinical trial. Circulation 1988 0.89
58 High level expression in 293 cells of the herpes simplex virus type 2 ribonucleotide reductase subunit 2 using an adenovirus vector. J Gen Virol 1990 0.89
59 Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise. Am J Med 1978 0.89
60 Hemodynamic differences between supine and upright exercise in patients with congestive heart failure. Circulation 1982 0.88
61 Detection of proteolytic enzymes after cellulose acetate electrophoresis. Anal Biochem 1969 0.88
62 Combinatorial blockade of calcineurin and CD28 signaling facilitates primary and secondary therapeutic gene transfer by adenovirus vectors in dystrophic (mdx) mouse muscles. J Virol 1998 0.87
63 Dynamic relation between myocardial contractility and energy metabolism during and following brief coronary occlusion in the pig. Circ Res 1990 0.87
64 Clinical and electrophysiologic findings in patients with paroxysmal slowing of the sinus rate and apparent Mobitz type II atrioventricular block. Circulation 1978 0.86
65 Adenovirus-based libraries: efficient generation of recombinant adenoviruses by positive selection with the adenovirus protease. Gene Ther 2002 0.86
66 Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects. Ann Intern Med 1980 0.86
67 Use of the Centritech Lab centrifuge for perfusion culture of hybridoma cells in protein-free medium. Biotechnol Prog 1997 0.85
68 Dose-dependent reduction of apoptosis in nutrient-limited cultures of NS/0 myeloma cells transfected with the E1B-19K adenoviral gene. Biotechnol Bioeng 1999 0.85
69 Relationship between myocardial metabolites and contractile abnormalities during graded regional ischemia. Phosphorus-31 nuclear magnetic resonance studies of porcine myocardium in vivo. J Clin Invest 1990 0.85
70 pGATA: a positive selection vector based on the toxicity of the transcription factor GATA-1 to bacteria. Biotechniques 1996 0.85
71 Adenovirus-mediated gene transfer into striated muscles. J Mol Med (Berl) 1995 0.85
72 Dystrophin expression in muscle following gene transfer with a fully deleted ("gutted") adenovirus is markedly improved by trans-acting adenoviral gene products. Hum Gene Ther 2001 0.84
73 Adenoviral-expressed GP5 of porcine respiratory and reproductive syndrome virus differs in its cellular maturation from the authentic viral protein but maintains known biological functions. Arch Virol 2003 0.84
74 Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy. Hum Gene Ther 2000 0.84
75 Epicardial and endocardial localized 31P magnetic resonance spectroscopy: evidence for metabolic heterogeneity during regional ischemia. Magn Reson Med 1990 0.84
76 Apoptosis-resistant E1B-19K-expressing NS/0 myeloma cells exhibit increased viability and chimeric antibody productivity under perfusion culture conditions. Biotechnol Bioeng 1999 0.84
77 Cloning and characterization of the human 5,10-methenyltetrahydrofolate synthetase-encoding cDNA. Gene 1995 0.84
78 Toxicity of replication-defective adenoviral recombinants in dissociated cultures of nervous tissue. Exp Neurol 1996 0.84
79 The R1 subunit of herpes simplex virus ribonucleotide reductase is a good substrate for host cell protein kinases but is not itself a protein kinase. J Biol Chem 1998 0.83
80 Culture of insect cells in helical ribbon impeller bioreactor. Biotechnol Bioeng 1991 0.83
81 Induction of humoral and cellular immune responses against the nucleocapsid of bovine viral diarrhea virus by an adenovirus vector with an inducible promoter. Virology 1999 0.83
82 Use of a micromanipulator for high-efficiency cloning of cells co-expressing fluorescent proteins. Methods Cell Sci 2000 0.83
83 Induction of apoptosis in oxygen-deprived cultures of hybridoma cells. Cytotechnology 1994 0.83
84 Sensitivity of 5-fluorouracil-resistant cancer cells to adenovirus suicide gene therapy. Cancer Gene Ther 2006 0.82
85 Hybridoma perfusion systems: a comparison study. Biotechnol Bioeng 1992 0.82
86 Myocardial perfusion scintigraphy in patients with mitral valve prolapse: Its advantage over stress electrocardiography in diagnosing associated coronary artery disease and its implications for the etiology of chest pain. Circulation 1978 0.82
87 Production of the R2 subunit of ribonucleotide reductase from herpes simplex virus with prokaryotic and eukaryotic expression systems: higher activity of R2 produced by eukaryotic cells related to higher iron-binding capacity. Biochem J 1996 0.82
88 Response of myocardial metabolites to graded regional ischemia: 31P NMR spectroscopy of porcine myocardium in vivo. Circ Res 1989 0.81
89 Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study. Eur J Heart Fail 1999 0.81
90 Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice. Gene Ther 1998 0.81
91 Efficient utrophin expression following adenovirus gene transfer in dystrophic muscle. Biochem Biophys Res Commun 1998 0.81
92 Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure. Am Heart J 2000 0.81
93 Baculovirus expression system scaleup by perfusion of high-density Sf-9 cell cultures. Biotechnol Bioeng 1994 0.80
94 High-level recombinant protein production in bioreactors using the baculovirus-insect cell expression system. Biotechnol Bioeng 1990 0.80
95 Rapidly progressive coronary artery bypass graft atherosclerosis. Report of a case documented by serial coronary arteriograms and pathologic examination. Chest 1981 0.80
96 Immunosuppression by FK506 markedly prolongs expression of adenovirus-delivered transgene in skeletal muscles of adult dystrophic [mdx] mice. Biochem Biophys Res Commun 1995 0.80
97 Understanding factors that limit the productivity of suspension-based perfusion cultures operated at high medium renewal rates. Biotechnol Bioeng 2000 0.80
98 Hemodynamic and radionuclide effects of acute captopril therapy for heart failure: changes in left and right ventricular volumes and function at rest and during exercise. Circulation 1982 0.80
99 Nuclear magnetic resonance imaging-guided phosphorus-31 spectroscopy of the human heart. J Am Coll Cardiol 1988 0.80
100 Escherichia coli and herpes-simplex-virus ribonucleotide reductase R2 subunit. Compared reactivities of the redox centres. Biochem J 1993 0.80
101 Electrophysiologic effects on combined autonomic blockade in patients with sinus node disease. Circulation 1981 0.80
102 Congenital abnormalities of the conduction system in two patients with tachyarrhythmias. Circulation 1979 0.80
103 Recombinant adenoviruses expressing the E2 protein of bovine viral diarrhea virus induce humoral and cellular immune responses. FEMS Microbiol Lett 1999 0.79
104 Sustained production of a soluble IGF-I receptor by gutless adenovirus-transduced host cells protects from tumor growth in the liver. Cancer Gene Ther 2013 0.79
105 Efficient muscle-specific transgene expression after adenovirus-mediated gene transfer in mice using a 1.35 kb muscle creatine kinase promoter/enhancer. Gene Ther 1997 0.79
106 Effects of chronic methadone administration on the hypothalamic-pituitary-thyroid axis. J Clin Endocrinol Metab 1972 0.78
107 A detailed physical and genetic map of two R.ColBM IncFIII plasmids. Plasmid 1984 0.78
108 Impairment of force generation after adenovirus-mediated gene transfer to muscle is alleviated by adenoviral gene inactivation and host CD8+ T cell deficiency. Hum Gene Ther 1996 0.78
109 Left ventricular hypertrophy reversal with labetalol and propranolol: a prospective randomized, double-blind study. Cardiovasc Drugs Ther 1990 0.78
110 Clinical magnetic resonance spectroscopy of brain, heart, liver, kidney, and cancer. A quantitative approach. NMR Biomed 1989 0.78
111 Alterations of skeletal muscle metabolism in humans studied by phosphorus 31 magnetic resonance spectroscopy in congestive heart failure. Am J Cardiol 1988 0.78
112 Association between the exercise ejection fraction response and systolic wall stress in patients with chronic aortic insufficiency. Circulation 1985 0.78
113 Genetically engineering mammalian cell lines for increased viability and productivity. Biotechnol Adv 1994 0.78
114 Metabolic and functional consequences of blunted myocardial reactive hyperemia. Am J Physiol 1991 0.78
115 Energetics of acute pressure overload of the porcine right ventricle. In vivo 31P nuclear magnetic resonance. J Clin Invest 1992 0.77
116 Immune responses induced by replication-defective adenovirus expressing the C-terminal portion of the Mycoplasma hyopneumoniae P97 adhesin. Clin Vaccine Immunol 2007 0.77
117 Veterans Affairs congestive heart failure antiarrhythmic trial. CHF STAT Investigators. Am J Cardiol 1993 0.77
118 Affinity of synthetic peptides for the HSV-2 ribonucleotide reductase R1 subunit measured with an iodinated photoaffinity peptide. Anal Biochem 1994 0.77
119 The immunosuppressant FK506 prolongs transgene expression in brain following adenovirus-mediated gene transfer. Neuroreport 1997 0.77
120 In vivo phosphorus-31 spectroscopic imaging in patients with global myocardial disease. Am J Cardiol 1990 0.77
121 Congestive heart failure: survival trial of antiarrhythmic therapy (CHF STAT). The CHF STAT Investigators. Control Clin Trials 1992 0.76
122 Improved yields of the extracellular domain of the epidermal growth factor receptor produced using the baculovirus expression system by medium replacement following infection. Appl Microbiol Biotechnol 1995 0.76
123 Adverse effects of sympatholytic agents in patients with hypertension and sinus node dysfunction. Am J Med 1978 0.76
124 Magnetic resonance spectroscopy of the heart. Cardiol Clin 1989 0.75
125 Apoptosis-resistant NS/0 E1B-19K myelomas exhibit increased viability and chimeric antibody productivity under cell cycle modulating conditions. Cytotechnology 1998 0.75
126 Suspected epidemiological relationships among strains of Escherichia coli O55:B5 confirmed by restriction pattern analysis of the carried plasmid (RColBM IncFIII). Ann Microbiol (Paris) 1982 0.75
127 Magnetic resonance spectroscopy. Evaluation of ischemic heart disease. Invest Radiol 1989 0.75
128 Biochemical properties and processing of the three major structural proteins of PRRS virus expressed by recombinant adenoviruses. Structural, functional and community aspects. Adv Exp Med Biol 2001 0.75
129 Myocardial high-energy phosphates in reactive hyperemia. Am J Physiol 1990 0.75
130 Updated diagnosis and management of congestive heart failure. Geriatrics 1986 0.75
131 Significant living without Warnock. Spec Educ Forward Trends 1982 0.75
132 Contrast enhancement of thallium-201 myocardial scintigrams: improved sensitivity with diminished specificity in coronary disease detection. Am Heart J 1981 0.75
133 Postural hypotension and tachycardia during hydralazine--isosorbide dinitrate therapy for chronic heart failure. Circulation 1981 0.75
134 Effects of stopping long-term vasodilator therapy in patients with chronic aortic insufficiency. Chest 1992 0.75
135 Echocardiography in ischemic heart disease: present status and future prospectives. Am Heart J 1978 0.75
136 Assessing the severity of aortic stenosis. Ann Intern Med 1979 0.75
137 Study of adenovirus-mediated dystrophin minigene transfer to skeletal muscle by combined microscopic display of adenoviral DNA and dystrophin. Hum Gene Ther 1997 0.75
138 Correlates of aortic distensibility in chronic aortic regurgitation and relation to progression to surgery. J Am Coll Cardiol 1992 0.75
139 Effect of delay in imaging. J Nucl Med 1986 0.75
140 Education and the disabled. Physiotherapy 1974 0.75
141 [The manner of rupture in heart insufficiency. ACE-inhibition more as vasodilation--indications]. Fortschr Med Suppl 1987 0.75
142 Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure. Am Heart J 1982 0.75
143 Monotherapy in mild to moderate hypertension: comparison of hydrochlorothiazide, propranolol and prazosin. Am J Cardiol 1984 0.75
144 Tetracycline-regulatable adenovirus vectors: pharmacologic properties and clinical potential. Eur J Pharm Sci 2001 0.75
145 Scale-up of recombinant virus and protein production in stirred-tank reactors. Methods Mol Biol 1995 0.75
146 Effects of long-term vasodilator therapy on electrocardiographic abnormalities in chronic aortic regurgitation. Am J Cardiol 1991 0.75